FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034146561> ?p ?o ?g. }

• W2034146561 endingPage "1930" @default.
• W2034146561 startingPage "1930" @default.
• W2034146561 abstract "We performed a meta-analysis of randomized controlled trials to assess ongoing concerns about the safety profile of combination angiotensin II receptor blockers (ARBs) plus angiotensin-converting enzyme (ACE) inhibitors in symptomatic left ventricular dysfunction.MEDLINE (January 1966-December 2006) and Web sites for the National Institute of Health Clinical Trials and the Food and Drug Administration were searched for eligible RCTs that included 500 or more subjects, had a follow-up of 3 months or longer, and reported adverse effects. We used a random effects model to calculate the relative risk (RR) and 95% confidence interval (CI) for the following outcome measures: medication discontinuations because of adverse effects, worsening renal function (an increase in serum creatinine level of > 0.5 mg/dL [to convert to micromoles per liter, multiply by 88.4]), hyperkalemia (serum potassium level > 5.5 mEq/L [to convert to millimoles per liter, multiply by 1]), and symptomatic hypotension.Four studies (N = 17 337; mean follow-up, 25 months [range, 11-41 months]) were selected. Combination ARB plus ACE inhibitor vs control treatment that included ACE inhibitors was associated with significant increases in medication discontinuations because of adverse effects in patients with chronic heart failure (RR, 1.38 [95% CI, 1.22-1.55]) or in patients with acute myocardial infarction with symptomatic left ventricular dysfunction (RR, 1.17 [95% CI, 1.03-1.34]), and for both conditions there were significant increases in worsening renal function (RR, 2.17 [95% CI, 1.59-2.97] and RR, 1.61 [95% CI, 1.31-1.98], respectively), hyperkalemia (RR, 4.87 [95% CI, 2.39-9.94] and RR, 1.33 [95% CI, 0.90-1.98], respectively; the latter was not significant), and symptomatic hypotension (RR, 1.50 [95% CI, 1.09-2.07], and RR, 1.48 [95% CI, 1.33-3.18], respectively).Combination ARB plus ACE inhibitor therapy in subjects with symptomatic left ventricular dysfunction was accompanied by marked increases in adverse effects." @default.
• W2034146561 created "2016-06-24" @default.
• W2034146561 creator A5044812036 @default.
• W2034146561 creator A5046153400 @default.
• W2034146561 creator A5079034841 @default.
• W2034146561 creator A5088028306 @default.
• W2034146561 creator A5090457083 @default.
• W2034146561 date "2007-10-08" @default.
• W2034146561 modified "2023-10-13" @default.
• W2034146561 title "Adverse Effects of Combination Angiotensin II Receptor Blockers Plus Angiotensin-Converting Enzyme Inhibitors for Left Ventricular Dysfunction" @default.
• W2034146561 cites W1964130755 @default.
• W2034146561 cites W1970448985 @default.
• W2034146561 cites W1975603373 @default.
• W2034146561 cites W1986215651 @default.
• W2034146561 cites W1986248422 @default.
• W2034146561 cites W1986360186 @default.
• W2034146561 cites W1988576223 @default.
• W2034146561 cites W1997455782 @default.
• W2034146561 cites W2000442546 @default.
• W2034146561 cites W2004544390 @default.
• W2034146561 cites W2021557771 @default.
• W2034146561 cites W2022605934 @default.
• W2034146561 cites W2023644538 @default.
• W2034146561 cites W2034063870 @default.
• W2034146561 cites W2035376102 @default.
• W2034146561 cites W2046121962 @default.
• W2034146561 cites W2050707117 @default.
• W2034146561 cites W2056736967 @default.
• W2034146561 cites W2056893352 @default.
• W2034146561 cites W2058399305 @default.
• W2034146561 cites W2069653988 @default.
• W2034146561 cites W2076524480 @default.
• W2034146561 cites W2082069148 @default.
• W2034146561 cites W2083923088 @default.
• W2034146561 cites W20910285 @default.
• W2034146561 cites W2093559613 @default.
• W2034146561 cites W2094727696 @default.
• W2034146561 cites W2098662245 @default.
• W2034146561 cites W2098780362 @default.
• W2034146561 cites W2099882339 @default.
• W2034146561 cites W2105969958 @default.
• W2034146561 cites W2107328434 @default.
• W2034146561 cites W2109198509 @default.
• W2034146561 cites W2109474061 @default.
• W2034146561 cites W2110062302 @default.
• W2034146561 cites W2110831147 @default.
• W2034146561 cites W2124737750 @default.
• W2034146561 cites W2124764590 @default.
• W2034146561 cites W2126887196 @default.
• W2034146561 cites W2130426015 @default.
• W2034146561 cites W2132517877 @default.
• W2034146561 cites W2132800785 @default.
• W2034146561 cites W2133084764 @default.
• W2034146561 cites W2140766694 @default.
• W2034146561 cites W2147761570 @default.
• W2034146561 cites W2152334831 @default.
• W2034146561 cites W2158604717 @default.
• W2034146561 cites W2158628485 @default.
• W2034146561 cites W2165165387 @default.
• W2034146561 cites W2168907840 @default.
• W2034146561 cites W2169516159 @default.
• W2034146561 cites W2361896195 @default.
• W2034146561 cites W3209204398 @default.
• W2034146561 cites W1529335551 @default.
• W2034146561 cites W2153502437 @default.
• W2034146561 doi "https://doi.org/10.1001/archinte.167.18.1930" @default.
• W2034146561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17923591" @default.
• W2034146561 hasPublicationYear "2007" @default.
• W2034146561 type Work @default.
• W2034146561 sameAs 2034146561 @default.
• W2034146561 citedByCount "175" @default.
• W2034146561 countsByYear W20341465612012 @default.
• W2034146561 countsByYear W20341465612013 @default.
• W2034146561 countsByYear W20341465612014 @default.
• W2034146561 countsByYear W20341465612015 @default.
• W2034146561 countsByYear W20341465612016 @default.
• W2034146561 countsByYear W20341465612017 @default.
• W2034146561 countsByYear W20341465612018 @default.
• W2034146561 countsByYear W20341465612019 @default.
• W2034146561 countsByYear W20341465612020 @default.
• W2034146561 countsByYear W20341465612021 @default.
• W2034146561 countsByYear W20341465612022 @default.
• W2034146561 countsByYear W20341465612023 @default.
• W2034146561 crossrefType "journal-article" @default.
• W2034146561 hasAuthorship W2034146561A5044812036 @default.
• W2034146561 hasAuthorship W2034146561A5046153400 @default.
• W2034146561 hasAuthorship W2034146561A5079034841 @default.
• W2034146561 hasAuthorship W2034146561A5088028306 @default.
• W2034146561 hasAuthorship W2034146561A5090457083 @default.
• W2034146561 hasBestOaLocation W20341465611 @default.
• W2034146561 hasConcept C126322002 @default.
• W2034146561 hasConcept C159641895 @default.
• W2034146561 hasConcept C164705383 @default.
• W2034146561 hasConcept C197934379 @default.
• W2034146561 hasConcept C27016395 @default.
• W2034146561 hasConcept C2778198053 @default.
• W2034146561 hasConcept C2780243291 @default.
• W2034146561 hasConcept C2780306776 @default.

• next